These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24639337)

  • 21. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
    Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
    Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.
    Wohlgemuth M; Lemmers RJ; Jonker M; van der Kooi E; Horlings CG; van Engelen BG; van der Maarel SM; Padberg GW; Voermans NC
    Neurology; 2018 Jul; 91(5):e444-e454. PubMed ID: 29997197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2.
    Calandra P; Cascino I; Lemmers RJ; Galluzzi G; Teveroni E; Monforte M; Tasca G; Ricci E; Moretti F; van der Maarel SM; Deidda G
    J Med Genet; 2016 May; 53(5):348-55. PubMed ID: 26831754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy.
    Greco A; Goossens R; van Engelen B; van der Maarel SM
    Clin Genet; 2020 Jun; 97(6):799-814. PubMed ID: 32086799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facioscapulohumeral muscular dystrophy-Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease.
    Vincenten SCC; Van Der Stoep N; Paulussen ADC; Mul K; Badrising UA; Kriek M; Van Der Heijden OWH; Van Engelen BGM; Voermans NC; De Die-Smulders CEM; Lassche S
    Clin Genet; 2022 Feb; 101(2):149-160. PubMed ID: 34297364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two Cases of Facioscapulohumeral Muscular Dystrophy 2 in Korea.
    Lee JH; Park HJ; Seong MW; Park SS; Choi YC
    Yonsei Med J; 2021 Jan; 62(1):95-98. PubMed ID: 33381940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.
    Lemmers RJLF; van der Vliet PJ; Vreijling JP; Henderson D; van der Stoep N; Voermans N; van Engelen B; Baas F; Sacconi S; Tawil R; van der Maarel SM
    Hum Mol Genet; 2018 Oct; 27(20):3488-3497. PubMed ID: 30281091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory muscle weakness in facioscapulohumeral muscular dystrophy.
    Henke C; Spiesshoefer J; Kabitz HJ; Herkenrath S; Randerath W; Brix T; Görlich D; Young P; Boentert M
    Muscle Nerve; 2019 Dec; 60(6):679-686. PubMed ID: 31566774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
    Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
    Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FSHD1 or FSHD2: That is the question: The answer: It's all just FSHD.
    Johnson NE; Statland JM
    Neurology; 2019 May; 92(19):881-882. PubMed ID: 30979855
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD.
    Balog J; Thijssen PE; de Greef JC; Shah B; van Engelen BG; Yokomori K; Tapscott SJ; Tawil R; van der Maarel SM
    Epigenetics; 2012 Jun; 7(6):579-84. PubMed ID: 22522912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2.
    van den Boogaard ML; Lemmers RJ; Camaño P; van der Vliet PJ; Voermans N; van Engelen BG; Lopez de Munain A; Tapscott SJ; van der Stoep N; Tawil R; van der Maarel SM
    Eur J Hum Genet; 2016 Jan; 24(1):78-85. PubMed ID: 25782668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory pattern in an adult population of dystrophic patients.
    D'Angelo MG; Romei M; Lo Mauro A; Marchi E; Gandossini S; Bonato S; Comi GP; Magri F; Turconi AC; Pedotti A; Bresolin N; Aliverti A
    J Neurol Sci; 2011 Jul; 306(1-2):54-61. PubMed ID: 21529845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory function in facioscapulohumeral muscular dystrophy 1.
    Wohlgemuth M; Horlings CGC; van der Kooi EL; Gilhuis HJ; Hendriks JCM; van der Maarel SM; van Engelen BGM; Heijdra YF; Padberg GW
    Neuromuscul Disord; 2017 Jun; 27(6):526-530. PubMed ID: 28416348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
    Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
    Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy.
    Eichinger K; Heatwole C; Heininger S; Stinson N; Matichak Stock C; Grosmann C; Wagner KR; Tawil R; Statland JM;
    Muscle Nerve; 2017 Mar; 55(3):333-337. PubMed ID: 27421252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.